Docality.com Logo
 
Dr. Atilla  Kayalar  Md image

Dr. Atilla Kayalar Md

6 Hearts Way
Queensbury NY 12804
518 921-1233
Medical School: Other - 2001
Accepts Medicare: Yes
Participates In eRX: Yes
Participates In PQRS: No
Participates In EHR: Yes
License #: 253569
NPI: 1518958610
Taxonomy Codes:
207RC0000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Atilla Kayalar is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:99222 Description:Initial hospital care Average Price:$279.76 Average Price Allowed
By Medicare:
$127.56
HCPCS Code:93306 Description:Tte w/doppler complete Average Price:$190.00 Average Price Allowed
By Medicare:
$62.91
HCPCS Code:99233 Description:Subsequent hospital care Average Price:$180.00 Average Price Allowed
By Medicare:
$96.58
HCPCS Code:99215 Description:Office/outpatient visit est Average Price:$180.48 Average Price Allowed
By Medicare:
$103.26
HCPCS Code:93880 Description:Extracranial study Average Price:$105.00 Average Price Allowed
By Medicare:
$28.54
HCPCS Code:78452 Description:Ht muscle image spect mult Average Price:$145.00 Average Price Allowed
By Medicare:
$74.63
HCPCS Code:99232 Description:Subsequent hospital care Average Price:$131.75 Average Price Allowed
By Medicare:
$67.38
HCPCS Code:93295 Description:Icd device interrogat remote Average Price:$125.00 Average Price Allowed
By Medicare:
$63.02
HCPCS Code:99204 Description:Office/outpatient visit new Average Price:$182.14 Average Price Allowed
By Medicare:
$121.31
HCPCS Code:93280 Description:Pm device progr eval dual Average Price:$75.00 Average Price Allowed
By Medicare:
$37.43
HCPCS Code:93279 Description:Pm device progr eval sngl Average Price:$65.00 Average Price Allowed
By Medicare:
$31.06
HCPCS Code:93010 Description:Electrocardiogram report Average Price:$35.00 Average Price Allowed
By Medicare:
$8.21
HCPCS Code:93227 Description:Ecg monit/reprt up to 48 hrs Average Price:$50.00 Average Price Allowed
By Medicare:
$25.88
HCPCS Code:93016 Description:Cardiovascular stress test Average Price:$40.00 Average Price Allowed
By Medicare:
$21.58
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$91.45 Average Price Allowed
By Medicare:
$73.42
HCPCS Code:93018 Description:Cardiovascular stress test Average Price:$25.00 Average Price Allowed
By Medicare:
$14.56
HCPCS Code:99406 Description:Behav chng smoking 3-10 min Average Price:$15.00 Average Price Allowed
By Medicare:
$11.24

HCPCS Code Definitions

93016
Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report
93010
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only
78452
Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection
93880
Duplex scan of extracranial arteries; complete bilateral study
93306
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography
93295
Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable cardioverter-defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional
93227
External electrocardiographic recording up to 48 hours by continuous rhythm recording and storage; review and interpretation by a physician or other qualified health care professional
93018
Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only
93280
Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system
93279
Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; single lead pacemaker system
99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
99204
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.
99215
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 40 minutes are spent face-to-face with the patient and/or family.
99222
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of moderate severity. Typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit.
99233
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is unstable or has developed a significant complication or a significant new problem. Typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit.
99232
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.
99406
Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1699793539
Cardiovascular Disease (Cardiology)
4,604
1982606984
Cardiovascular Disease (Cardiology)
2,930
1730177825
Nephrology
2,748
1649265398
Diagnostic Radiology
1,699
1215918313
Vascular Surgery
1,605
1336299551
Urology
1,521
1013999820
Family Practice
1,456
1699883918
Family Practice
1,441
1487668968
Family Practice
1,357
1245244649
Family Practice
1,356
*These referrals represent the top 10 that Dr. Kayalar has made to other doctors

Publications

Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study. - Circulation
Increased arterial stiffness and higher plasma natriuretic peptide and homocysteine levels are associated with elevated risk for cardiovascular disease. Little is known about the relations of natriuretic peptides and homocysteine to arterial wall stiffness in the community.We assessed the relations of plasma N-terminal atrial natriuretic peptide, B-type natriuretic peptide, adrenomedullin, and homocysteine concentrations to arterial stiffness in participants in the Framingham Heart Study. Central pulse pressure, forward pressure wave, reflected pressure wave, carotid-femoral pulse wave velocity, and carotid-radial pulse wave velocity were assessed by tonometry in 1962 participants (mean age, 61 years; 56% women) in the Framingham Heart Study. Central systolic and diastolic blood pressures were 123/75 mm Hg in men and 119/66 mm Hg in women. After adjustment for age and clinical covariates, N-terminal atrial natriuretic peptide and B-type natriuretic peptide were associated with carotid-femoral pulse wave velocity (men: partial correlation, 0.069, P = 0.043 and r = 0.115, P < or = 0.001, respectively; women: r = -0.063, P = 0.037 and r = -0.062, P = 0.040), and carotid-radial pulse wave velocity (men: r = -0.090, P = 0.009 and r = -0.083, P < or = 0.015; women: r = -0.140, P < or = 0.001 and r = -0.104, P = 0.001, respectively). In men, N-terminal atrial natriuretic peptide and B-type natriuretic peptide also were associated with forward and reflected wave and carotid pulse pressure. In men, adrenomedullin was associated with mean arterial pressure (r = 0.089, P = 0.009), and homocysteine was associated with carotid-femoral pulse wave velocity (r = 0.072, P = 0.036), forward pressure (r = 0.079, P = 0.02), and central pulse pressure (r = 0.072, P = 0.035). Interaction tests indicated sex differences in the relations of several biomarkers to measures of arterial stiffness.Plasma natriuretic peptide, adrenomedullin, and homocysteine levels are associated with alterations in conduit vessel properties that differ in men and women.
Prehypertension and risk of cardiovascular disease. - Expert review of cardiovascular therapy
Epidemiologic data have established a continuous relationship between vascular risk and blood pressure that extends down to levels as low as 115/75 mmHg, emphasizing the lack of a critical threshold value that defines 'high' blood pressure. Acknowledging the graded and continuous nature of the relations of blood pressure to vascular risk, the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VII) introduced the new category 'prehypertension' to describe people with a systolic blood pressure between 120 and 139 mmHg and/or a diastolic blood pressure between 80 and 89 mmHg. It is estimated that 31% of the US population (70 million) has prehypertension. The risk of cardiovascular disease within this large prehypertensive population is not uniform, however, and increases with a rising concomitant burden of other vascular risk factors. Accordingly, a strategy of estimating global cardiovascular risk (by applying standardized risk prediction algorithms) and adjusting the intensity of blood pressure lowering (and reduction of other risk factors) to the absolute risk of cardiovascular disease is desirable in prehypertensive individuals. Adopting a healthier lifestyle, as recommended by JNC VII, is a critical component of the therapeutic approach to prehypertension.

Map & Directions

6 Hearts Way Queensbury, NY 12804
View Directions In Google Maps

Nearby Doctors

1St Advantage Dental 1092 Route 9
Queensbury, NY 12804
518 989-9561
5 Main St Suite 6
Queensbury, NY 12804
518 982-2225
551 Bay Rd
Queensbury, NY 12804
518 985-5046
68 Quaker Rd
Queensbury, NY 12804
518 935-5601
1092 Route 9
Queensbury, NY 12804
518 989-9561
25 Willowbrook Road Suite 2
Queensbury, NY 12804
518 939-9156
25 Baywood Drive
Queensbury, NY 12804
518 936-6329
453 Dixon Rd
Queensbury, NY 12804
518 921-1108
41 Fox Hollow Ln
Queensbury, NY 12804
518 457-7670
35 Wildwood Place Queensbury Imaging Specialist, Pc
Queensbury, NY 12804
518 439-9699